Priit Pruunsild
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Priit Pruunsild has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Hilmar Bading
Department of Neurobiology, Interdisciplinary Center for Neurosciences (IZN), Heidelberg University, 69120 Heidelberg, Germany
2 shared publications - Andry Andrianarivelo
Université Paris Cité, CNRS, Saints-Pères Paris Institute for the Neurosciences, Paris, France
1 shared publication Anu Hark
Department of Chemistry and Biotechnology, Tallinn University of Technology, 12618 Tallinn, Estonia
1 shared publicationBenoit Forget
INSERM, UMR-S 1130 Neuroscience Paris Seine Institute of Biology Paris Seine Paris France
1 shared publication- Brady J. Maher
Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, USA
1 shared publication Charlotte Piette
Center for Interdisciplinary Research in Biology (CIRB) College de France CNRS UMR7241 INSERM U1050 Université PSL Paris France
1 shared publication
Latest Publications
- Open Access
- 3 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1743
Inhba, Homer1 and Bdnf are major targets of transcriptomic dysregulation by neurodegenerative disease-associated excitotoxic NMDA receptor signaling
Synaptic activity-regulated gene expression supports neuroprotection, plasticity, and memory. The transcription factor CREB is central to these processes. It is activated by synaptic NMDA receptors but inactivated by excitotoxic extrasynaptic NMDAR (esNMDAR) signaling. Using primary hippocampal neurons, we modeled neurodegeneration and found that esNMDAR activation, which causes CREB shut-off and inactivation of the ERK/MAPK-ELK1/SRF pathway, extensively distorted control of synaptic activity over transcription. This resulted in the suppression of key neuroprotective genes, in particular Inhba and Bdnf , but also of genes involved in synaptic function ( Homer1 , Btg2 , Mir132 , Mir212 ) and transcription factor genes ( Atf3 , Egr1 , Fos , Npas4 ). In a Huntington’s disease (HD) mouse model, treatment with memantine or targeting the NMDAR/TRPM4 complex with FP802 restored gene expression, notably Inhba , Homer1 and Bdnf , and attenuated the decrease of the HD disease marker Ppp1r1b (DARPP-32). These findings identify esNMDAR-driven transcriptional dysregulation as a key pathomechanism in neurodegenerative disease, supporting inhibition of esNMDAR-signaling as a promising therapeutic approach.
- 3 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1743
Open AccessInhba, Homer1 and Bdnf are major targets of transcriptomic dysregulation by neurodegenerative disease-associated excitotoxic NMDA receptor signaling
Synaptic activity-regulated gene expression supports neuroprotection, plasticity, and memory. The transcription factor CREB is central to these processes. It is activated by synaptic NMDA receptors but inactivated by excitotoxic extrasynaptic NMDAR (esNMDAR) signaling. Using primary hippocampal neurons, we modeled neurodegeneration and found that esNMDAR activation, which causes CREB shut-off and inactivation of the ERK/MAPK-ELK1/SRF pathway, extensively distorted control of synaptic activity over transcription. This resulted in the suppression of key neuroprotective genes, in particular Inhba and Bdnf , but also of genes involved in synaptic function ( Homer1 , Btg2 , Mir132 , Mir212 ) and transcription factor genes ( Atf3 , Egr1 , Fos , Npas4 ). In a Huntington’s disease (HD) mouse model, treatment with memantine or targeting the NMDAR/TRPM4 complex with FP802 restored gene expression, notably Inhba , Homer1 and Bdnf , and attenuated the decrease of the HD disease marker Ppp1r1b (DARPP-32). These findings identify esNMDAR-driven transcriptional dysregulation as a key pathomechanism in neurodegenerative disease, supporting inhibition of esNMDAR-signaling as a promising therapeutic approach.
- Open Access
- 18 October 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (12) , e51882
Npas4 regulates medium spiny neuron physiology and gates cocaine-induced hyperlocomotion
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 18 October 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (12) , e51882
Open AccessNpas4 regulates medium spiny neuron physiology and gates cocaine-induced hyperlocomotion
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 26 September 2017
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 37 (43) , 10516-10527
The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A
Transcription factor 4 (TCF4 also known as ITF2 or E2-2) is a basic helix-loop-helix (bHLH) protein associated with Pitt–Hopkins syndrome, intellectual disability, and schizophrenia (SCZ). Here, we show that TCF4-dependent transcription in cortical neurons cultured from embryonic rats of both sexes is induced by neuronal activity via soluble adenylyl cyclase and protein kinase A (PKA) signaling. PKA phosphorylates TCF4 directly and a PKA phosphorylation site in TCF4 is necessary for its transcriptional activity in cultured neurons and in the developing brainin vivo. We also demonstrate thatGadd45g(growth arrest and DNA damage inducible gamma) is a direct target of neuronal-activity-induced, TCF4-dependent transcriptional regulation and that TCF4 missense variations identified in SCZ patients alter the transcriptional activity of TCF4 in neurons. This study identifies a new role for TCF4 as a neuronal-activity-regulated transcription factor, offering a novel perspective on the association of TCF4 with cognitive disorders.SIGNIFICANCE STATEMENTThe importance of the basic helix-loop-helix transcription factor transcription factor 4 (TCF4) in the nervous system is underlined by its association with common and rare cognitive disorders. In the current study, we show that TCF4-controlled transcription in primary cortical neurons is induced by neuronal activity and protein kinase A. Our results support the hypotheses that dysregulation of neuronal-activity-dependent signaling plays a significant part in the etiology of neuropsychiatric and neurodevelopmental disorders.
- 26 September 2017
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 37 (43) , 10516-10527
Open AccessThe Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A
Transcription factor 4 (TCF4 also known as ITF2 or E2-2) is a basic helix-loop-helix (bHLH) protein associated with Pitt–Hopkins syndrome, intellectual disability, and schizophrenia (SCZ). Here, we show that TCF4-dependent transcription in cortical neurons cultured from embryonic rats of both sexes is induced by neuronal activity via soluble adenylyl cyclase and protein kinase A (PKA) signaling. PKA phosphorylates TCF4 directly and a PKA phosphorylation site in TCF4 is necessary for its transcriptional activity in cultured neurons and in the developing brainin vivo. We also demonstrate thatGadd45g(growth arrest and DNA damage inducible gamma) is a direct target of neuronal-activity-induced, TCF4-dependent transcriptional regulation and that TCF4 missense variations identified in SCZ patients alter the transcriptional activity of TCF4 in neurons. This study identifies a new role for TCF4 as a neuronal-activity-regulated transcription factor, offering a novel perspective on the association of TCF4 with cognitive disorders.SIGNIFICANCE STATEMENTThe importance of the basic helix-loop-helix transcription factor transcription factor 4 (TCF4) in the nervous system is underlined by its association with common and rare cognitive disorders. In the current study, we show that TCF4-controlled transcription in primary cortical neurons is induced by neuronal activity and protein kinase A. Our results support the hypotheses that dysregulation of neuronal-activity-dependent signaling plays a significant part in the etiology of neuropsychiatric and neurodevelopmental disorders.